Nationwide Fund Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-34,773
| Closed | -$1.88M | – | 3430 |
|
|
2016
Q1 | $1.88M | Buy |
34,773
+562
| +2% | +$30.4K | 0.01% | 1379 |
|
|
2015
Q4 | $3.87M | Buy |
34,211
+52
| +0.2% | +$5.88K | 0.02% | 1064 |
|
|
2015
Q3 | $4.02M | Sell |
34,159
-2,429
| -7% | -$286K | 0.02% | 1026 |
|
|
2015
Q2 | $2.83M | Sell |
36,588
-2,398
| -6% | -$186K | 0.01% | 1252 |
|
|
2015
Q1 | $2.26M | Sell |
38,986
-804
| -2% | -$46.5K | 0.01% | 1402 |
|
|
2014
Q4 | $1.28M | Sell |
39,790
-224
| -0.6% | -$7.22K | 0.01% | 1679 |
|
|
2014
Q3 | $979K | Buy |
40,014
+14,761
| +58% | +$361K | ﹤0.01% | 1844 |
|
|
2014
Q2 | $448K | Buy |
+25,253
| New | +$448K | ﹤0.01% | 2322 |
|
|
2014
Q1 | – | Sell |
-19,523
| Closed | -$328K | – | 3359 |
|
|
2013
Q4 | $328K | Sell |
19,523
-698
| -3% | -$11.7K | ﹤0.01% | 2446 |
|
|
2013
Q3 | $215K | Buy |
20,221
+4,427
| +28% | +$47.1K | ﹤0.01% | 2618 |
|
|
2013
Q2 | $88K | Buy |
+15,794
| New | +$88K | ﹤0.01% | 2839 |
|